MSB 10.4% $1.49 mesoblast limited

Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-255

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,865 Posts.
    lightbulb Created with Sketch. 1350
    Yeah recruitment might be more efficient, but they're recruiting many more people.

    The last one took what, 8 years from approval?

    So it's definitely at least a couple years for the next - that's a fair assumption, no?

    Am I wrong?
    Last edited by DocMcstuffins: 24/01/24
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.